Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 673195, 4 pages
http://dx.doi.org/10.1155/2015/673195
Case Report

Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria

1Department of Medical Sciences, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
2Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
3Department of Internal Medicine, Hitachi, Ltd., Hitachinaka General Hospital, Hitachinaka 312-0057, Japan

Received 4 April 2015; Accepted 27 May 2015

Academic Editor: Ramon Tiu

Copyright © 2015 Haruhiko Ninomiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-I. Nishimura, Y. Kanakura, R. E. Ware et al., “Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan,” Medicine, vol. 83, no. 3, pp. 193–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Clark, S. A. Butler, V. Braren, R. C. Hartmann, and D. E. Jenkins Jr., “The kidneys in paroxysmal nocturnal hemoglobinuria,” Blood, vol. 57, no. 1, pp. 83–89, 1981. View at Google Scholar · View at Scopus
  3. P. Hillmen, C. Hall, J. C. W. Marsh et al., “Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria,” The New England Journal of Medicine, vol. 350, no. 6, pp. 552–559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Hillmen, M. Elebute, R. Kelly et al., “Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria,” American Journal of Hematology, vol. 85, no. 8, pp. 553–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Hillmen, P. Muus, A. Röth et al., “Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria,” British Journal of Haematology, vol. 162, no. 1, pp. 62–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Kanakura, K. Ohyashiki, T. Shichishima et al., “Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial,” International Journal of Hematology, vol. 98, no. 4, pp. 406–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Kanakura, K. Ohyashiki, T. Shichishima et al., “Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial,” International Journal of Hematology, vol. 93, no. 1, pp. 36–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Matsuo, E. Imai, M. Horio et al., “Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982–992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Suzukawa, H. Ninomiya, S. Mitsuhashi, I. Anno, T. Nagasawa, and T. Abe, “Demonstration of the deposition of hemosiderin in the kidneys of patients with paroxysmal nocturnal hemoglobinuria by magnetic resonance imaging,” Internal Medicine, vol. 32, no. 9, pp. 686–690, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Mathieu, A. Rahmouni, P. Villeneuve, M. C. Anglade, H. Rochant, and N. Vasile, “Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria,” Blood, vol. 85, no. 11, pp. 3283–3288, 1995. View at Google Scholar · View at Scopus
  11. A. L. Riley, L. M. Ryan, and D. A. Roth, “Renal proximal tubular dysfunction and paroxysmal nocturnal hemoglobinuria,” The American Journal of Medicine, vol. 62, no. 1, pp. 125–129, 1977. View at Publisher · View at Google Scholar · View at Scopus
  12. P.-J. Hsiao, S.-C. Wang, M.-C. Wen, L.-K. Diang, and S.-H. Lin, “Fanconi syndrome and CKD in a patient with paroxysmal nocturnal hemoglobinuria and hemosiderosis,” American Journal of Kidney Diseases, vol. 55, no. 1, pp. e1–e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Zachee, M. Henckens, B. van Damme, M. A. Boogaerts, H. Rigauts, and R. K. A. Verberckmoes, “Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria,” Clinical Nephrology, vol. 39, no. 1, pp. 28–31, 1993. View at Google Scholar · View at Scopus
  14. L. C. Herlitz, A. S. Bomback, G. S. Markowitz et al., “Pathology after eculizumab in dense deposit disease and C3 GN,” Journal of the American Society of Nephrology, vol. 23, no. 7, pp. 1229–1237, 2012. View at Publisher · View at Google Scholar · View at Scopus